2022, Number 4
Simultaneous systemic thrombosis as a manifestation of COVID-19
Borges-López JS, Mares-Orozco AR, Barón-Caballero JL, Ayala-Hernández E, Borges-López LM
Language: Spanish
References: 5
Page: 960-963
PDF size: 229.57 Kb.
ABSTRACT
Background: The current COVID-19 pandemic mainly affects the respiratory system; however, with the increase in cases worldwide, there is evidence of compromise at the cardiovascular level, which can manifest as acute myocardial infarction, myocarditis, pericarditis, myopericarditis, heart failure, cardiogenic shock, vasculitis, deep vein thrombosis, pulmonary embolism, ischemic stroke, acute arterial insufficiency, arrhythmias, and sudden death.Clinical case: A 70-year-old male patient who simultaneously presented multisystemic thrombosis manifested by cerebral vascular event, pulmonary thromboembolism, acute myocardial infarction and acute arterial insufficiency in the context of SARSCoV- 2 pneumonia.
Conclusions: In patients with COVID-19 there is a high thrombogenic potential secondary to blood stasis, hypercoagulability and endothelial dysfunction, which worsens the prognosis and increases mortality, mainly in patients who require ICU stay, so an adequate thromboprophylactic or anticoagulant scheme and follow-up in the convalescent phase must be provided to detect sequelae associated with COVID-19.
REFERENCES